Obsessive-compulsive disorder and attention-deficit/hyperactivity disorder: distinct associations with DNA methylation and genetic variation.


Journal

Journal of neurodevelopmental disorders
ISSN: 1866-1955
Titre abrégé: J Neurodev Disord
Pays: England
ID NLM: 101483832

Informations de publication

Date de publication:
16 08 2020
Historique:
received: 18 11 2019
accepted: 28 07 2020
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 18 9 2021
Statut: epublish

Résumé

A growing body of research has demonstrated associations between specific neurodevelopmental disorders and variation in DNA methylation (DNAm), implicating this molecular mark as a possible contributor to the molecular etiology of these disorders and/or as a novel disease biomarker. Furthermore, genetic risk variants of neurodevelopmental disorders have been found to be enriched at loci associated with DNAm patterns, referred to as methylation quantitative trait loci (mQTLs). We conducted two epigenome-wide association studies in individuals with attention-deficit/hyperactivity disorder (ADHD) or obsessive-compulsive disorder (OCD) (aged 4-18 years) using DNA extracted from saliva. DNAm data generated on the Illumina Human Methylation 450 K array were used to examine the interaction between genetic variation and DNAm patterns associated with these disorders. Using linear regression followed by principal component analysis, individuals with the most endorsed symptoms of ADHD or OCD were found to have significantly more distinct DNAm patterns from controls, as compared to all cases. This suggested that the phenotypic heterogeneity of these disorders is reflected in altered DNAm at specific sites. Further investigations of the DNAm sites associated with each disorder revealed that despite little overlap of these DNAm sites across the two disorders, both disorders were significantly enriched for mQTLs within our sample. Our DNAm data provide insights into the regulatory changes associated with genetic variation, highlighting their potential utility both in directing GWAS and in elucidating the pathophysiology of neurodevelopmental disorders.

Sections du résumé

BACKGROUND
A growing body of research has demonstrated associations between specific neurodevelopmental disorders and variation in DNA methylation (DNAm), implicating this molecular mark as a possible contributor to the molecular etiology of these disorders and/or as a novel disease biomarker. Furthermore, genetic risk variants of neurodevelopmental disorders have been found to be enriched at loci associated with DNAm patterns, referred to as methylation quantitative trait loci (mQTLs).
METHODS
We conducted two epigenome-wide association studies in individuals with attention-deficit/hyperactivity disorder (ADHD) or obsessive-compulsive disorder (OCD) (aged 4-18 years) using DNA extracted from saliva. DNAm data generated on the Illumina Human Methylation 450 K array were used to examine the interaction between genetic variation and DNAm patterns associated with these disorders.
RESULTS
Using linear regression followed by principal component analysis, individuals with the most endorsed symptoms of ADHD or OCD were found to have significantly more distinct DNAm patterns from controls, as compared to all cases. This suggested that the phenotypic heterogeneity of these disorders is reflected in altered DNAm at specific sites. Further investigations of the DNAm sites associated with each disorder revealed that despite little overlap of these DNAm sites across the two disorders, both disorders were significantly enriched for mQTLs within our sample.
CONCLUSIONS
Our DNAm data provide insights into the regulatory changes associated with genetic variation, highlighting their potential utility both in directing GWAS and in elucidating the pathophysiology of neurodevelopmental disorders.

Identifiants

pubmed: 32799817
doi: 10.1186/s11689-020-09324-3
pii: 10.1186/s11689-020-09324-3
pmc: PMC7429807
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Subventions

Organisme : CIHR
ID : MOP-106573
Pays : Canada
Organisme : CIHR
ID : MOP-93696
Pays : Canada
Organisme : Ontario Brain Institute
ID : IDS-I l-02
Pays : International
Organisme : NIMH NIH HHS
ID : R01 MH101493
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085321
Pays : United States

Références

Genome Res. 2014 Jul;24(7):1064-74
pubmed: 24709820
PLoS Genet. 2011 Aug;7(8):e1002228
pubmed: 21852959
Genome Biol. 2012 Feb 09;13(2):R8
pubmed: 22322129
Mol Psychiatry. 2018 May;23(5):1181-1188
pubmed: 28761083
Nat Rev Mol Cell Biol. 2018 Apr;19(4):207-208
pubmed: 29339796
Nat Rev Genet. 2009 Dec;10(12):872-8
pubmed: 19859063
Am J Psychiatry. 1993 Dec;150(12):1792-8
pubmed: 8238632
Am J Psychiatry. 2016 Dec 1;173(12):1213-1222
pubmed: 27363509
Cell. 2016 Nov 17;167(5):1398-1414.e24
pubmed: 27863251
Biol Psychiatry. 2005 Jun 1;57(11):1313-23
pubmed: 15950004
Biol Psychiatry. 2019 Oct 15;86(8):599-607
pubmed: 31003786
Depress Anxiety. 2002;16(2):59-63
pubmed: 12219336
Genome Biol. 2016 Aug 30;17(1):176
pubmed: 27572077
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):884-97
pubmed: 20732625
Int J Educ Psychol Assess. 2012 Apr;10(1):51-70
pubmed: 26504617
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Am J Hum Genet. 2013 Nov 7;93(5):876-90
pubmed: 24183450
Curr Psychiatry Rep. 2011 Oct;13(5):333-44
pubmed: 21779823
Nat Genet. 2013 Oct;45(10):1150-9
pubmed: 23974872
Am J Hum Genet. 2017 May 4;100(5):773-788
pubmed: 28475860
Neurotherapeutics. 2012 Jul;9(3):490-9
pubmed: 22976615
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Mol Psychiatry. 2012 Sep;17(9):880-6
pubmed: 22688191
Biol Psychiatry. 2007 Feb 1;61(3):316-21
pubmed: 16950231
J Am Acad Child Adolesc Psychiatry. 1996 Mar;35(3):343-51
pubmed: 8714323
Acta Paediatr. 2007 Sep;96(9):1269-74
pubmed: 17718779
BMC Psychiatry. 2007 Jun 20;7:26
pubmed: 17584500
PLoS One. 2012;7(7):e41361
pubmed: 22848472
PLoS Genet. 2012;8(4):e1002629
pubmed: 22532803
Nat Genet. 2019 Jan;51(1):63-75
pubmed: 30478444
Nat Commun. 2015 Dec 22;6:10207
pubmed: 26690673
Epigenetics. 2013 Apr;8(4):445-54
pubmed: 23538714
J Am Acad Child Adolesc Psychiatry. 2016 Apr;55(4):310-318.e4
pubmed: 27015722
J Abnorm Child Psychol. 2013 Apr;41(3):497-507
pubmed: 23315233
Genome Biol. 2011;12(1):R10
pubmed: 21251332
Mol Psychiatry. 2012 Oct;17(10):960-87
pubmed: 22105624
Transl Psychiatry. 2014 Jan 07;4:e339
pubmed: 24399042
J Child Psychol Psychiatry. 2019 Sep;60(9):988-997
pubmed: 30908652
Am J Psychiatry. 2020 Mar 1;177(3):223-232
pubmed: 31906708
Mol Psychiatry. 2013 Jul;18(7):788-98
pubmed: 22889921
Clin Psychol Rev. 2011 Dec;31(8):1361-72
pubmed: 22024245
Mol Psychiatry. 2015 Mar;20(3):337-44
pubmed: 24821223
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Twin Res Hum Genet. 2005 Oct;8(5):450-8
pubmed: 16212834
Mol Psychiatry. 2017 Feb;22(2):250-256
pubmed: 27217153
Pediatr Rev. 1993 Dec;14(12):455-65
pubmed: 8115282
J Child Psychol Psychiatry. 2016 Feb;57(2):152-60
pubmed: 26304033
J Autism Dev Disord. 2007 Feb;37(2):251-9
pubmed: 16865546
Am J Med Genet B Neuropsychiatr Genet. 2015 Jan;168B(1):36-44
pubmed: 25355443
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Nat Rev Genet. 2017 Jul;18(7):441-451
pubmed: 28555657
Arch Gen Psychiatry. 2011 Dec;68(12):1267-75
pubmed: 22147844
Nat Rev Neurosci. 2014 Jun;15(6):410-24
pubmed: 24840803
Neurosci Biobehav Rev. 2016 Jun;65:36-62
pubmed: 27013116
J Am Acad Child Adolesc Psychiatry. 1997 Jun;36(6):844-52
pubmed: 9183141
Arch Gen Psychiatry. 2004 Jun;61(6):608-16
pubmed: 15184240
Sci Rep. 2016 Aug 16;6:31333
pubmed: 27527274
Nature. 2007 May 24;447(7143):396-8
pubmed: 17522671
Nature. 2008 Nov 6;456(7218):18-21
pubmed: 18987709
BMC Neurosci. 2016 Nov 30;17(1):79
pubmed: 27903255
J Am Acad Child Adolesc Psychiatry. 2002 Jan;41(1):52-8
pubmed: 11800207
J Psychiatr Res. 2019 Jul;114:17-23
pubmed: 31004918
J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):896-905.e6
pubmed: 27663945
Clin Epigenetics. 2019 Jul 16;11(1):103
pubmed: 31311581
Nat Rev Dis Primers. 2015 Aug 06;1:15020
pubmed: 27189265
Neuropsychopharmacology. 2016 Oct;41(11):2679-87
pubmed: 27184339
Transl Psychiatry. 2019 Oct 3;9(1):242
pubmed: 31582733
Nat Neurosci. 2016 Jan;19(1):40-7
pubmed: 26619358
Psychol Med. 2005 Feb;35(2):237-43
pubmed: 15841681

Auteurs

Sarah J Goodman (SJ)

Genetics and Genome Biology, SickKids Hospital, Toronto, ON, Canada.

Christie L Burton (CL)

Neurosciences and Mental Health Program, SickKids Hospital, Toronto, ON, Canada.

Darci T Butcher (DT)

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

Michelle T Siu (MT)

Biochemical Genetics Laboratory, Alberta Children's Hospital, Calgary, AB, Canada.

Mathieu Lemire (M)

Neurosciences and Mental Health Program, SickKids Hospital, Toronto, ON, Canada.

Eric Chater-Diehl (E)

Genetics and Genome Biology, SickKids Hospital, Toronto, ON, Canada.

Andrei L Turinsky (AL)

Genetics and Genome Biology, SickKids Hospital, Toronto, ON, Canada.
Centre for Computational Medicine, SickKids Hospital, Toronto, ON, Canada.

Michael Brudno (M)

Genetics and Genome Biology, SickKids Hospital, Toronto, ON, Canada.
Centre for Computational Medicine, SickKids Hospital, Toronto, ON, Canada.
Department of Computer Science, University of Toronto, Toronto, ON, Canada.

Noam Soreni (N)

Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.

David Rosenberg (D)

Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, USA.

Kate D Fitzgerald (KD)

Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.

Gregory L Hanna (GL)

Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.

Evdokia Anagnostou (E)

Holland Bloorview Kids Rehabilitation Hospital Toronto, Toronto, ON, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada.

Paul D Arnold (PD)

Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, AB, Canada.
Departments of Psychiatry and Medical Genetics, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Jennifer Crosbie (J)

Neurosciences and Mental Health Program, SickKids Hospital, Toronto, ON, Canada.

Russell Schachar (R)

Neurosciences and Mental Health Program, SickKids Hospital, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Rosanna Weksberg (R)

Genetics and Genome Biology, SickKids Hospital, Toronto, ON, Canada. rweksb@sickkids.ca.
Institute of Medical Science, University of Toronto, Toronto, ON, Canada. rweksb@sickkids.ca.
Division of Clinical and Metabolic Genetics, SickKids Hospital, Toronto, ON, Canada. rweksb@sickkids.ca.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. rweksb@sickkids.ca.
Department of Paediatrics, University of Toronto, Toronto, ON, Canada. rweksb@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH